Regonix 40 mg (Regorafenib)
Regorafenib is an oral multi-kinase inhibitor involved in normal cellular functioning and in pathological processes such as oncogenesis, tumor angiogenesis, metastasis, and tumor immunity. It is used in the therapy of metastatic colorectal cancer, gastrointestinal stromal tumor, and hepatocellular carcinoma (HCC) who have been previously treated with Sorafenib.
Product Features:
Product Name: Regonix
Generic Name : Regorafenib
Formulation: Tablet
Available Pack Size: 28’s
Available Strengths: 40mg
Categories: Anti-Cancer
Manufacturer: Beacon Pharmaceuticals Ltd.
